An update on Medication Related Osteonecrosis of the Jaw (DWD04MARCH2027)

AvailabilityPlaces available  Add to basket
SubjectOsteonecrosis of the Jaw
DescriptionThere have been significant developments in our knowledge and understanding of MRONJ in the last few years, as well as many new drugs that have been implicated in the disease. This webinar will provide an overview of both old and new drugs implicated in the disease, relevant guidelines for clinical practice and discuss how dentists should be preventing and managing the disease in primary and secondary care settings. Whilst aimed primarily towards dentists in primary care settings, this session may also be of benefit to the wider dental team.
VenueMicrosoft Teams, Microsoft Teams - Virtual  View details
Date & timeThursday 4 March 2027, 19:00 to 20:00
LecturerClaire Wilson  View details
Target audience

Mandatory: Dental Hygienist (£5.00pp discount), or Dental Nurse (£5.00pp discount), or Dental Technician (£5.00pp discount), or Dental Therapist (£5.00pp discount), or Orthodontic Therapist (£5.00pp discount), or Dentist

Course styleLecture
CategoryEvening lecture
CateringNo catering
Development outcomeC
CPD hours1:00
Cost£10.00 (subject to discounts, see Target audience above)
Aims

To provide an update on MRONJ and drugs implicated in the disease.

Objectives
  • Provide an update on the current understanding of drugs implicated in the MRONJ disease process
  • Review the current guidelines on MRONJ
  • Discuss the ways to minimise the risk of MRONJ and management options for established MRONJ including referral pathways
Learning outcomes
  • Have an awareness of the different groups of drugs implicated in MRONJ and what patient groups may be taking these.
  • Have an awareness of the current MRONJ guidelines.
  • Understand how to minimise the risk of MRONJ and how to manage a case including when and how to onward refer.